首页> 外文会议>World biomaterials congress >Anti-tumor and repairing nerve injuries: A drug-loaded monosialoganliosides micelles delivered to brain for glioblastoma
【24h】

Anti-tumor and repairing nerve injuries: A drug-loaded monosialoganliosides micelles delivered to brain for glioblastoma

机译:抗肿瘤和修复神经损伤:载有药物的单唾液​​酸神经节苷脂胶束被递送至脑胶质母细胞瘤

获取原文

摘要

Introduction: Compared with clinical remission and extending life, quality of life in patients with glioblastoma have not been given enough attention in clinical treatment. Nerve injuries directly or indirectly effect on life of patients with glioblastoma. And the treatment of brain cancers remains great challenges because most of the therapeutic drugs can't be delivered to the tumors in the brain directly for the existence of blood-brain barrier (BBB) Therefore, we applied monosialoganglioside GM1 as drug-loaded nanosized carrier, which is amphiphilic molecules that spontaneously self-assemble into micelles. Moreover, GM1 is a kind of drug that can cross the BBB and treat neurological disease, exogenously administered GM1 have been proved to provoke regeneration and neurite outgrowth in the injured nervous system. The anti-tumor drugs can be encapsulated in self-assembled micelles of GM1 and are delivered to brain. Therefore, this drug delivery system has the capabilities of overcoming BBB, repairing nerve injuries, and eliminating tumor cells. Materials and Methods: Stock solution of DOX were prepared by dissolving the drug in dimethylsulfoxide (DMSO). Stock solution of purified monosialogangliosides GM1 were prepared by dissolving the gangliosides in tri-distilled water, and the solution were maintained at 4°C, they should be centrifuged and filtered prior to use. Stock solutions of DOX were slowly added to the solution of GM1 micelles. Then the mixed micelles were incubated at 4°C for 24h and dialyzed for 24h. The structure and morphology were characterized by TEM, and the mean diameter and its distribution were measured by means of Zetasizer. The method of DIR-loaded micelles is consistent with the preparation of mixed micelles of GM1 and DOX. Fluorescent micelles were injected intravenously in the caudal vein. Discussion and Conclusion: The morphology of micelles was detected using a JEM 1200EX transmission electron microscope. Fig A showed micelles GM1/DOX mixed micelles with about 20nm of mean diameter tends to evenly distributed. A normal mouse was injected with GM1/DIR micelles, distribution and intensity of DIR were monitored by In-Vivo FX PRO for small animal imaging. It revealed that GM1 can cross blood-brain barrier and target to brain because DIR were concentrated mainly in the brain tissue. (Fig.B).
机译:简介:与临床缓解和延长寿命相比,胶质母细胞瘤患者的生活质量在临床治疗中并未得到足够的重视。神经损伤直接或间接影响胶质母细胞瘤患者的生活。脑癌的治疗仍然是一个巨大的挑战,因为大多数治疗药物由于血脑屏障(BBB)的存在而无法直接递送至脑部肿瘤,因此,我们将单唾液酸神经节苷脂GM1用作载药纳米载体,这是两性分子,自发地自组装成胶束。此外,GM1是一种可以穿越BBB并治疗神经系统疾病的药物,已证明外源施用GM1可以在受伤的神经系统中引起再生和神经突生长。可以将抗肿瘤药物封装在GM1的自组装胶束中,然后传递到大脑。因此,该药物输送系统具有克服血脑屏障,修复神经损伤和消除肿瘤细胞的能力。材料与方法:通过将药物溶解在二甲亚砜(DMSO)中制备DOX储备溶液。通过将神经节苷脂溶解在三蒸馏水中来制备纯化的单唾液酸神经节苷脂GM1的储备溶液,并将溶液保持在4°C,应将其离心并过滤后再使用。将DOX的储备溶液缓慢添加到GM1胶束溶液中。然后将混合的胶束在4°C下孵育24h,并透析24h。用TEM表征其结构和形态,并通过Zetasizer测量平均直径及其分布。载有DIR的胶束的方法与GM1和DOX混合胶束的制备方法一致。将荧光胶束静脉注射到尾静脉中。讨论和结论:使用JEM 1200EX透射电子显微镜检测了胶束的形态。图A显示了胶束GM1 / DOX混合胶束,平均直径约为20nm。向正常小鼠注射GM1 / DIR胶束,通过In-Vivo FX PRO监测DIR的分布和强度,以进行小动物成像。这表明GM1可以穿过血脑屏障并靶向大脑,因为DIR主要集中在大脑组织中。 (图B)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号